Welcome to LookChem.com Sign In|Join Free
  • or
Ethanone, 1-(2,4-dimethyl-1H-pyrrol-3-yl)-2,2,2-trifluoro- (9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

202286-38-2

Post Buying Request

202286-38-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

202286-38-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 202286-38-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,2,2,8 and 6 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 202286-38:
(8*2)+(7*0)+(6*2)+(5*2)+(4*8)+(3*6)+(2*3)+(1*8)=102
102 % 10 = 2
So 202286-38-2 is a valid CAS Registry Number.

202286-38-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(2,4-dimethyl-1H-pyrrol-3-yl)-2,2,2-trifluoroethanone

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:202286-38-2 SDS

202286-38-2Downstream Products

202286-38-2Relevant academic research and scientific papers

PYRIDYLPYRROLE COMPOUNDS USEFUL AS INTERLEUKIN-AND TNF ANTAGONISTS

-

, (2008/06/13)

The present invention provides a compound of the formula: and its pharmaceutically acceptable salts, wherein R1, R2, R3, R4, R5 and m are as defined in claim 1. The present invention also provides processes for the preparation thereof, the use thereof in treating cytokines mediated diseases and/or cell adhesion molecules (CAMs) mediated diseases and pharmaceutical compositions for use in such therapy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 202286-38-2